Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had revenue of $1.07B in the quarter ending March 31, 2026, with 19.05% growth. This brings the company's revenue in the last twelve months to $4.44B, up 9.20% year-over-year. In the year 2025, Jazz Pharmaceuticals had annual revenue of $4.27B with 4.88% growth.

• Revenue (ttm): $4.44B
• Revenue Growth: +9.20%
• P/S Ratio: 2.94
• Revenue / Employee: $1,535,878
• Employees: 2,890
• Market Cap: 13.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.27B	198.64M	4.88%
Dec 31, 2024	4.07B	234.75M	6.12%
Dec 31, 2023	3.83B	174.83M	4.78%
Dec 31, 2022	3.66B	565.14M	18.26%
Dec 31, 2021	3.09B	730.67M	30.91%

Data Source: S&P Global Market Intelligence Last updated: May 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error